Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer

This study has been completed.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: March 7, 2000
Last updated: August 8, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2001
  Estimated Primary Completion Date: No date given